Opening bell for Biocapital Europe 2017
On the morning of 14 March 2017, the Euronext Amsterdam markets were opened with a bell ceremony to celebrate the start of BioCapital Europe 2017. Geraldine O’Keeffe, Partner at LSP (Life Science Partners) and conference host, sounded the gong in recognition of the 15th anniversary of the event. Watch the video below!
BioCapital Europe 2017 takes place on 15 March 2017 in Amsterdam, The Netherlands, at the historic hotel Sofitel Legend The Grand Amsterdam. The conference is organized by LSP, a leading independent European investment firm, providing financing for private and public life-science companies. Euronext is a sponsor of the conference.
BioCapital Europe is Europe’s premier life sciences investment conference, offering VCs and Institutional Investors unique and timely access to around 40 exciting biotech, medtech and diagnostics companies from the Benelux and Europe at a crucial stage of their development. The presenting companies for this years’ event are developing cutting edge, innovative healthcare solutions to a variety of diseases such as novel treatments for cancer, ground breaking medical devices for stroke and heart disease, in additional to breakthrough diagnostics and therapies for a wide range of diseases.
In 2016, the event attracted over 200 attendees (mainly CEOs, CFOs, pharma execs, VCs, and Institutional Investors).
EnterNext’s Joost Kromhout, Head of Listing for Euronext Amsterdam, is one of the conference’s primary speakers, presenting the biotech market in context of the stock exchange, and how it may be leveraged to the advantage of these ground-breaking companies.
Take a look at the event’s programme here.
Relive the 2016 edition of Biocapital Europe here.